CRVS ▼ -0.6% - Corvus Pharmaceuticals, Inc. $CRVS - Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial 27-AUG-2026 07:30 AM ET